Advertisement

Autoimmune Thyroid Disease in Pregnancy and the Postpartum Period

  • R. Jansson
  • A. Karlsson
Part of the Immunology and Medicine book series (IMME, volume 3)

Abstract

Pregnancy represents a specific immunologic situation because the fetus is recognized by the maternal immune system as an allograft which needs protection from being rejected by the mother. Numerous factors have been proposed as possible mediators of an immunosuppressive effect on an antifetal allograft response1,2. These include local mechanisms in the placenta, presence of serum inhibitory factors and/or maternal cellular hyporeactivity (Table 10.1). However, the primary events behind the development of tolerance against the fetal allograft are still largely unknown.

Keywords

Postpartum Period Iodine Deficiency Congenital Hypothyroidism Autoimmune Thyroiditis Autoimmune Thyroid Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gleicher, N. and Siegel, I. (1983). Pregnancy and the immune state. In Davies, T. F. (ed.) Autoimmune Endocrine Disease pp. 225–45 (New York: John Wiley & Sons).Google Scholar
  2. Gall, S. A. (1983). Maternal adjustments in the immune system in normal pregnancy. Clin. Obstet, Gynecol., 26, 521–36.CrossRefGoogle Scholar
  3. 3.
    Burrow, G. N. (1985). The management of thyrotoxicosis in pregnancy. N. Engl. J. Med., 313, 562–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Davies, T. F. and Cobin, R. (1985). Thyroid disease in pregnancy and the postpartum period. Mt. Sinai. J. Med., 52, 59–77.PubMedGoogle Scholar
  5. 5.
    Weetman, A. P. and McGregor, A. M. (1984). Autoimmune thyroid disease: developments in our understanding. Endocr. Rev., 5, 309–55.PubMedCrossRefGoogle Scholar
  6. 6.
    Burman, K. D. and Baker Jr., J. R. (1985). Immune mechanisms in Graves’ disease. Endocr. Rev., 6, 183–232.PubMedCrossRefGoogle Scholar
  7. 7.
    Tunbridge, W. M. G., Brewis, M., French, J. M., Appleton, D., Bird, T., Clark, F., Evered, D. C., Grimley Evans, J., Hall, R., Smith, P., Stephenson, J. and Young, E. (1981). Natural history of autoimmune thyroiditis. Br. Med. J., 282, 258–62.CrossRefGoogle Scholar
  8. 8.
    Portmann, L., Hamada, N., Heinrich, G. and DeGroot, L. J. (1985). Anti-thyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with antimicrosomal antibody. J. Clin. Endocrinol. Metab., 61, 1001–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Walfish, P. G. and Farid, N. R. (1985). The immunogenetic basis of autoimmune thyroid disease. In Walfish, P. G., Wall, J. R. and Volpe, R. (eds). Autoimmunity and the Thyroid. pp. 9–36. (Orlando: Academic Press).Google Scholar
  10. 10.
    Jansson, R., Safwenberg, J. and Dahlberg, P. A. (1985). Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis. J. Clin. Endocrinol. Metab., 60, 168–73.PubMedCrossRefGoogle Scholar
  11. 11.
    Bottazzo, G. F., Pujol-Borrell, R., Hanafusa, T. and Feldmann, M. (1983). Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet, 2, 1115–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Momotani, N., Ito, K., Hamada, N., Ban, Y., Nishikawa, Y. and Mimura, T. (1984). Maternal hyperthyroidism and congenital malformations in the offspring. Clin. Endocrinol., 20, 695–700.CrossRefGoogle Scholar
  13. 13.
    Montoro, M., Collea, J. V., Frasier, S. D. and Mestman, J. H. (1981). Successful outcome of pregnancy in women with hypothyroidism. Ann. Intern. Med., 94, 31–4.PubMedGoogle Scholar
  14. Man, E. B., Jones, W. S., Holden, R. H. and Mellits, D. E. (1971). Thyroid function in human pregnancy. VIII. Retardation of progeny aged 7 years; relationship to maternal age and maternal thyroid function. Am. J. Obstet. Gynecol., III, 905–16.Google Scholar
  15. 15.
    Hetzel, B. (1983). Iodine deficiency disorders (IDD) and their eradication. Lancet.,2,1126–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Fisher, D. A. (1983). Maternal-fetal thyroid function in pregnancy. Clin. Perinatol., 10, 615–26.PubMedGoogle Scholar
  17. 17.
    Glorieux, J., Dussault, J. H., Letarte, J., Guyda, H. and Morisette, J. (1983). Preliminary results on the mental development of hypothyroid infants detected by the Quebec screening program. J. Pediatr., 102, 19–22.PubMedCrossRefGoogle Scholar
  18. Escobar del Rey, F., Pastor, R., Mallol, J. and Morreale de Escobar, G. (1985). Effects of maternal iodine deficiency on T4 and T3 contents of rat concepta, before and after onset of fetal thyroid function. Presented at the 9th International Thyroid Congress, September 1–6, Sao Paolo, Brazil.Google Scholar
  19. Morreale de Escobar, G., Pastor, R., Obregon, M. J. and Escobar del Rey, F. (1985). Effects of maternal thyroidectomy on rat embryonic T4 and T3 contents and development before and after onset of fetal thyroid function. Presented at the 9th International Thyroid Congress, September 1–6, Sao Paolo, Brazil.Google Scholar
  20. 20.
    Oka, M. (1953). Effect of pregnancy on the onset and course of rheumatoid arthritis. Ann. Rheum. Dis., 12, 227.PubMedCrossRefGoogle Scholar
  21. 21.
    Gardiner-Hill, H. (1929). Pregnancy complicating simple goitre and Graves’ disease. Lancet, 1, 120–4.CrossRefGoogle Scholar
  22. 22.
    Nelson, J. C. and Palmer, F. J. (1974). A remission of goitrous hypothyroidism during pregnancy. J. Clin. Endocrinol. Me tab., 40, 383–6.CrossRefGoogle Scholar
  23. 23.
    Amino, N. and Miyai, K. (1983). Postpartum autoimmune endocrine syndromes. In Davies, T. F. (ed.) Autoimmune Endocrine Disease, pp. 247–72 (New York: J. Wiley and Sons).Google Scholar
  24. 24.
    Amino, N., Tanizawa, O., Mori, H., Iwatani, Y., Yamada, T., Karachi, K., Kumahara, Y. and Miyai, K. (1982). Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves’disease. J. Clin. Endocrinol. Metab., 55, 108–12.PubMedCrossRefGoogle Scholar
  25. 25.
    Bovillon, R., Naesens, M., Van Assche, F. A., De Keyser, L., De Moor, P., Renaer, M., De Vos, P. and De Roo, M. (1982). Thyroid function in patients with hyperemesis gravidarum. Am. J. Obstet. Gynecol., 143, 922–6.Google Scholar
  26. 26.
    Jeffcoate, W. J. and Bain, C. (1985). Recurrent pregnancy-induced thyrotoxicosis presenting as hyperemesis gravidarum. Case report. Br. J. Obstet. Gynaecol., 92, 413–5.CrossRefGoogle Scholar
  27. 27.
    Parker, R. H. and Beierwaltes, W. H. (1961). Thyroid antibodies during pregnancy and in the newborn. J. Clin. Endocrinol. Metab., 21, 792–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Amino, N., Kuro, R., Tanizawa, O., Tanaka, F., Hayashi, C., Kotani, K., Kawashima, M., Miyai, K. and Kumahara, Y. (1978). Changes of serum antithyroid antibodies during and after pregnancy in autoimmune thyroid diseases. Clin. Exp. Immunol., 31, 30–7.PubMedGoogle Scholar
  29. 29.
    Hardisty, C. A. and Munro, D. S. (1983). Serum long acting thyroid stimulator protector in pregnancy complicated by Graves’ disease. Br. Med. J., 286, 934–5.CrossRefGoogle Scholar
  30. 30.
    Dussault, J. H., Letarte, J., Guyda, H. and Laberge, C. (1980). Lack of influence of thyroid antibodies on thyroid function in the newborn infant and on a mass screening program for congenital hypothyroidism. J. Pediatr., 96, 385–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Ramsay, I., Kaur, S. and Krassas, G. (1983). Thyrotoxicosis in pregnancy: results of treatment by antithyroid drugs combined with T4. Clin. Endocrinol., 18, 73–85.CrossRefGoogle Scholar
  32. 32.
    Daneman, D. and Howard, N. J. (1980). Neonatal thyrotoxicosis, intellectual impairment and craniosynostasis in later years. J. Pediatr., 97, 257–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Cove, D. H. and Johnston, P. (1985). Fetal hyperthyroidism: experience of treatment of four siblings. Lancet, 1, 430–2.PubMedCrossRefGoogle Scholar
  34. 34.
    Munro, D. S., Dirmikis, S. M., Humphries, H., Smith, T. and Broadhead, G. D. (1978). The role of thyroid stimulating immunoglobulins of Graves’ disease in neonatal thyrotoxicosis. Br. J. Obstet. Gynaecol., 85, 837–43.PubMedCrossRefGoogle Scholar
  35. 35.
    Zakarija, M. and McKenzie, J. M. (1983). Pregnancy-associated changes in the thyroid- stimulating antibody of Graves’ disease and the relationship to neonatal hyperthyroidism. J. Clin. Endocrinol. Metab., 57, 1036–40.PubMedCrossRefGoogle Scholar
  36. 36.
    McGregor, A. M., Hall, R. and Richards, C. (1984). Autoimmune thyroid disease and pregnancy. Br. Med. J., 288, 1780–1.CrossRefGoogle Scholar
  37. 37.
    Matsuura, N., Yamada, Y., Nohara, Y., Konishi, J., Kasagi, K., Endo, K., Kojima, H. and Wataya, K. (1980). Familial neonatal transient hypothyroidism due to maternal TSH- binding inhibitor immunoglobulins. N. Engl. J. Med., 303, 737–41.CrossRefGoogle Scholar
  38. 38.
    Karlsson, F. A., Dahlberg, P. A. and Ritzen, E. M. (1984). Thyroid blocking antibodies in thyroiditis. Acta Med. Scand., 215, 461–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Zakarija, M., McKenzie, J. M. and Munro, D. S. (1983). Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves’ disease. J. Clin. Invest., 72, 1352–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Van der Gaag, R.D., Drexhage, H. A. and Dussault, J. H. (1985). Role of maternal immunoglobulins blocking TSH-induced thyroid growth in sporadic forms of congenital hypothyroidism. Lancet, 1, 246–50.PubMedCrossRefGoogle Scholar
  41. 41.
    Roberton, H. E. W. (1948). Lassitude, coldness, and hair changes following pregnancy, and their response to treatment with thyroid extract. Br. Med. J., 2, 93–4.CrossRefGoogle Scholar
  42. 42.
    Amino, N., Miyai, K., Onishi, T., Hashimoto, T., Arai, K., Ishibashi, K. and Kumahara, Y. (1976). Transient hypothyroidism after delivery in autoimmune thyroiditis. J. Clin. Endocrinol. Metab., 42, 296–301.PubMedCrossRefGoogle Scholar
  43. 43.
    Ginsberg, J. and Walfish, P. G. (1977). Post-partum transient thyrotoxicosis with painless thyroiditis. Lancet, 1, 1125–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Amino, N., Mori, H., Iwatani, Y., Tanizawa, O., Kawashima, M., Tsuge, I., Ibaragi, K., Kumahara, Y. and Miyai, K. (1982). High prevalence of transient postpartum thyrotoxicosis and hypothyroidism. N. Engl. J. Med., 306, 849–52.PubMedCrossRefGoogle Scholar
  45. 45.
    Jansson, R., Bernander, S., Karlsson, A., Levin, K. and Nilsson, G. (1984). Autoimmune thyroid dysfunction in the postpartum period. J. Clin. Endocrinol. Metab., 58, 681–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Walfish, P. G. and Chan, J. Y. C. (1985). Post-partum hyperthyroidism. Clin. Endocrinol. Metab., 14, 417–47.PubMedCrossRefGoogle Scholar
  47. Jansson, R. (1984). Autoimmune thyroiditis - a clinical, epidemiological and immunological study with special reference to transient aggravation in the postpartum period. (Thesis). Acta Univ. Ups., 492, 1–73.Google Scholar
  48. 48.
    Jansson, R., Thompson, P. M., Clark, F. and McLachlan, S. M. (1985). Association between thyroid microsomal antibodies of subclass IgGl and hypothyroidism in autoimmune postpartum thyroiditis. Clin. Exp. Immunol., 62.Google Scholar
  49. 49.
    Taylor, H. C. and Sheeler, L. R. (1982). Recurrence and heterogeneity in painless thyrotoxic lymphocytic thyroiditis. Report of five cases. J. Am. Med. Assoc., 248, 1085–8.Google Scholar
  50. 50.
    Jansson, R., Tôtterman, T. H., Sàllstrôm, J. and Dahlberg, P. A. (1984). Intrathyroidal and circulating lymphocyte subsets in different stages of autoimmune postpartum thyroiditis. J. Clin. Endocrinol. Metab., 58, 942–6.PubMedCrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1986

Authors and Affiliations

  • R. Jansson
  • A. Karlsson

There are no affiliations available

Personalised recommendations